ArticleJornal brasileiro de nefrologia
Brazilian dialysis survey 2019.
Article in Jornal brasileiro de nefrologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- An integrative review of APOL1 kidney disease with a focus on the Brazilian population.Clinics (Sao Paulo, Brazil) · 2026Review
- Maintenance of inequity in the provision of chronic dialysis treatment in Brazil.Jornal brasileiro de nefrologia · 2026Article
- Comparison of 1-year survival between patients initiating chronic hemodialysis under public and private health insurance: register-based data analysis from Brazil.International urology and nephrology · 2024Article
- Decadal Analysis of Age-Adjusted Mortality Rates for Acute and Chronic Kidney Disease in Brazil, 2000-2021.Cureus · 2024Article
- Epidemiological of chronic kidney disease based on a database of health.Revista da Associacao Medica Brasileira (1992) · 2024Article
- Overview of global healthcare policies for patients with chronic kidney disease: an integrative literature review.Einstein (Sao Paulo, Brazil) · 2024Review
- [Beneficiaries of private health plans that used the public outpatient hemodialysis network in Brazil between 2012 and 2019].Cadernos de saude publica · 2023Article
- Smartphone and application use in self-management of chronic kidney disease: a cross-sectional feasibility study.Sao Paulo medical journal = Revista paulista de medicina · 2022Article
- Article
- Brazilian Dialysis Survey 2020.Jornal brasileiro de nefrologiaArticle
- Profile of professionals working in intradialytic exercise programs in Brazil: a national survey.Jornal brasileiro de nefrologiaArticle
- Is screening for chronic kidney disease in patients with diabetes mellitus being properly conducted in primary care?Jornal brasileiro de nefrologiaArticle
- Hemodialysis in Brazil: differences across geographic regions regarding demographics, laboratory parameters and drug prescription.Jornal brasileiro de nefrologiaArticle
- Progression of valve heart disease in a cohort of patients undergoing renal replacement therapy.Jornal brasileiro de nefrologiaArticle
- Renal osteodystrophy in Brazil: the skeleton calls for greater attention!Jornal brasileiro de nefrologiaArticle
- Secondary hyperparathyroidism: what we know and what we are still learning.Jornal brasileiro de nefrologiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionNational data on chronic dialysis treatment are essential for the development of health policies that aim to improve the treatment of patients.
objectiveTo present data from the Brazilian Dialysis Survey 2019, promoted by the Brazilian Society of Nephrology.
methodsData collection from dialysis units in the country through a completed online questionnaire for 2019.
results314 (39%) centers responded the questionnaire. In July 2019, the estimated total number of patients on dialysis was 139,691. Estimates of the prevalence and incidence rates of patients undergoing dialysis treatment per million of the population (pmp) were 665 and 218, respectively, with mean annual increases of 25 pmp and 14 pmp for prevalence and incidence, respectively. The annual gross mortality rate was 18.2%. Of the prevalent patients, 93.2% were on hemodialysis and 6.8% on peritoneal dialysis; and 33,015 (23.6%) on the waiting list for transplantation. 55% of THE centers offered treatment with peritoneal dialysis. Venous catheters were used as access in 24.8% of THE patients on hemodialysis. 17% of the patients had K ≥ 6.0mEq/L; 2.5% required red blood cell transfusion in July 2019 and 10.8% of the patients had serum levels of 25-OH vitamin D < 20 ng/mL.
conclusionThe absolute number of patients, the incidence and prevalence rates in dialysis in the country continue to increase, as well as the percentage of patients using venous catheter as dialysis access. There was an increase in the number of patients on the list for transplantation and a tendency to reduce gross mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.